Online Only Articles

Successful tyrosine kinase inhibitor therapy in a refractory B-cell precursor acute lymphoblastic leukemia with EBF1-PDGFRB fusion

Adolescents and Young Adults Hematology Unit, APHP, Saint-Louis Hospital, Paris, France;EA-3518, Institute of Hematology (IUH), Univ Paris Diderot, Sorbonne Paris Cité, France
Hematology Laboratory, APHP, Saint-Louis Hospital, Paris, France
Adolescents and Young Adults Hematology Unit, APHP, Saint-Louis Hospital, Paris, France;EA-3518, Institute of Hematology (IUH), Univ Paris Diderot, Sorbonne Paris Cité, France
Hematology Laboratory, APHP, Saint-Louis Hospital, Paris, France;U944 INSERM, Institute of Hematology (IUH), Univ Paris Diderot, Sorbonne Paris Cité, France
Adolescents and Young Adults Hematology Unit, APHP, Saint-Louis Hospital, Paris, France;EA-3518, Institute of Hematology (IUH), Univ Paris Diderot, Sorbonne Paris Cité, France
Hematology Laboratory, APHP, Saint-Louis Hospital, Paris, France;U944 INSERM, Institute of Hematology (IUH), Univ Paris Diderot, Sorbonne Paris Cité, France;Department of Genetics, Robert Debré Hospital, Paris, France
Vol. 98 No. 11 (2013): November, 2013 https://doi.org/10.3324/haematol.2013.095372